FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, particularly to pharmacology and aspects of treating or preventing upper airway disorders, and describes an inhalable dry powder containing dry particles containing magnesium salt, as well as methods of treating a respiratory disease, treating a respiratory disease attack, treating or preventing an upper airway infection with the above methods involving administering an effective amount of the inhalable dry powder into the airway of the patient in need thereof. The particles according to the invention have high dispersive ability, no tendency for clustering despite its small size, and contain high concentrations of the active ingredient.
EFFECT: invention is applicable for therapy of upper airway diseases, as well as for making a medicinal preparation for treating, preventing, diagnosing upper airway disorders and/or infections.
25 cl, 37 dwg, 40 tbl, 26 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIFUNGAL DRY POWDERS | 2017 |
|
RU2766086C2 |
CATIONS OF MONOVALENT METALS OF DRY POWDERS FOR INHALATIONS | 2011 |
|
RU2640921C2 |
METHODS OF TREATING FUNGAL INFECTIONS | 2019 |
|
RU2820457C2 |
HIGH DOSE LEVODOPA CAPSULES FOR PULMONARY USE | 2013 |
|
RU2676093C2 |
METHOD FOR DELIVERING AEROSOL OF LARGE THERAPEUTIC MASS IN HIGHLY EFFECTIVE MODE | 2001 |
|
RU2275900C2 |
INHALATION COMPOSITIONS CONTAINING GLYCOPYRRONIUM SALTS | 2007 |
|
RU2453302C2 |
INHALATION PHARMACEUTICAL COMPOSITIONS | 2013 |
|
RU2697862C2 |
ULTRA LOW DENSITY INHALATION POWDERS | 2013 |
|
RU2670987C2 |
DRY POWDER COMPOSITIONS REPRESENTED AS PARTICLES WHICH CONTAIN TWO OR MORE ACTIVE INGREDIENTS FOR TREATMENT OF OBSTRUCTIVE OR INFLAMMATORY DISEASES OF RESPIRATORY WAYS | 2012 |
|
RU2629333C2 |
NICOTINE-CONTAINING PARTICLES | 2017 |
|
RU2741309C2 |
Authors
Dates
2016-03-20—Published
2010-03-26—Filed